42 reports

eClinical Solutions Market Size, Share & Trends Analysis Report By Product (eCOA, CTMS, EDC & CDMS), By Delivery Mode (Web-hosted, Licensed Enterprise, Cloud-based), By Development Phase, By End Use, By Region, And Segment Forecasts, 2022 - 2030 eClinical Solutions Market Growth & Trends The...

  • Pharmaceutical
  • Clinical Trial
  • Clinical Development
  • World

“Exosomes - Pipeline Insight, 2022” report provides comprehensive insights about 55+ companies and 70+ pipeline drugs in Exosomes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule...

  • Therapy
  • Clinical Development
  • World

“Glutamate Receptor Antagonist - Pipeline Insight, 2022” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Glutamate Receptor Antagonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type,...

  • Therapy
  • Clinical Trial
  • Clinical Development
  • World
  • Smoking Prevalence

“BET inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in BET inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Therapy
  • Clinical Development
  • Breast Cancer
  • World

“Proto-oncogene protein c-bcl-2 inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 16+ companies and 16+ pipeline drugs in Proto-oncogene protein c-bcl-2 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment...

  • Therapy
  • Clinical Development
  • China
  • World

“Platelet-derived growth factor receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Platelet-derived growth factor receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the...

  • Therapy
  • Cancer
  • Clinical Development
  • Targeted Therapy
  • World

“E-Selectin inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 7+ pipeline drugs in E-selectin inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Therapy
  • Clinical Development
  • China
  • World

“Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics...

  • Clinical Development
  • Psychotic Disorder
  • Therapy
  • World

“FTase (Farnesyltransferase) inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in FTase inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...

  • Clinical Development
  • Therapy
  • World

“Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Dihydroorotate Dehydrogenase (DHODH) Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics...

  • Therapy
  • Clinical Development
  • Neurological Disorder
  • World

“Amyloid precursor protein secretase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Amyloid precursor protein secretase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics...

  • Therapy
  • Dementia
  • Clinical Development
  • World

“5-HT2A Agonists - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in 5-HT2A Agonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Therapy
  • Drug Development
  • Clinical Development
  • Biopharmaceutical
  • Neurological Disorder
  • World

“Retinoic Acid Receptor (RARs) Agonist - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Retinoic Acid Receptor (RARs) Agonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by...

  • Therapy
  • Clinical Development
  • World

“14-Alpha Demethylase Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in 14-Alpha Demethylase Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type,...

  • Therapy
  • Antifungal
  • Clinical Development
  • World
  • United States

“MTORC1 Protein Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in MTORC1 Protein Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...

  • Therapy
  • Targeted Therapy
  • Drug Development
  • Clinical Development
  • Clinical Trial
  • World

“CXCR4 Receptor Antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in CXCR4 Receptor Antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage,...

  • Therapy
  • Clinical Development
  • Clinical Trial
  • World
  • United Kingdom

“Lysine Specific Demethylase 1 (LSD-1) Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 11+ companies and 11+ pipeline drugs in Lysine Specific Demethylase 1 (LSD-1) Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics...

  • Therapy
  • Clinical Development
  • World

“NF-kappa B Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in NF-kappa B Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of...

  • Therapy
  • Cancer
  • Clinical Development
  • Immunotherapy
  • Clinical Trial
  • World
  • Europe
  • United States

“Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Muscarinic Acetylcholine Receptor M1 Antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics...

  • Therapy
  • Drug Development
  • Clinical Development
  • World

“Cytidine Deaminase Inhibitors (CDA) - Pipeline Insight, 2022” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Cytidine Deaminase Inhibitors (CDA) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product...

  • Therapy
  • Clinical Development
  • Antiviral
  • World

“Protein 50S Ribosomal Subunit Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Protein 50S Ribosomal Subunit Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment...

  • Therapy
  • Clinical Development
  • Anti-Infective
  • China
  • World

“Ghrelin Receptor Agonist - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Ghrelin Receptor Agonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...

  • Therapy
  • Clinical Development
  • Clinical Trial
  • World

“Enoyl-ACP reductase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Enoyl-ACP reductase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type,...

  • Therapy
  • Anti-Infective
  • Clinical Development
  • World

“Purinoceptor P2Y12 antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Purinoceptor P2Y12 antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type,...

  • Therapy
  • Clinical Development
  • World
  • United States
  • Canada

“Isocitrate Dehydrogenase (IDH) inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Isocitrate Dehydrogenase (IDH) inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment...

  • Therapy
  • Clinical Development
  • Cancer
  • World

“TGF-Beta Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in TGF-Beta Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Therapy
  • Clinical Development
  • World

“RIPK1 inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 6+ pipeline drugs in RIPK1 inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Therapy
  • Dementia
  • Clinical Development
  • World

“Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Acetyl-CoA Carboxylase Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product...

  • Clinical Trial
  • Therapy
  • Clinical Development
  • Digestive System Disorder
  • World

“Apolipoprotein C-III inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Apolipoprotein C-III inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type,...

  • Therapy
  • Clinical Development
  • South Korea
  • World

“Lipoxygenase Inhibitor (LOX Inhibitor) - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Lipoxygenase Inhibitor (LOX Inhibitor) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment...

  • Therapy
  • Clinical Development
  • Type 2 Diabetes
  • Clinical Trial
  • Neurological Disorder
  • Digestive System Disorder
  • World